SMALL MOLECULE AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF

Technology
E-218-2021
Patent ID
E-218-2021-0-US-02
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
 
Publication Number
 
Application Number
18/837,100
IC
NCATS
Date Filed
Date Issued
 
Patent PDF
 
Related Technologies
TAB-3658     First-in-class Small Molecule Agonists of the Insulin-like (INSL3) Peptide Receptor RXFP2 and Uses in Bone Disorders and Fertility